|
| Exchange Disseminated Time | Merck Ltd has informed BSE that the members at the 41st Annual General Meeting (AGM) of the Company held on April 16, 2008, inter alia, have accorded the following:
1. Adoption of the audited Profit & Loss Account for the year ended December 31, 2007 and the Balance Sheet as on that date together with the Directors’ Report and the Auditors’ Report thereon.
2. Declaration of final dividend at the rate of Rs 10.00 per share for the year ended December 31, 2007.
3. Re-appointment of Mr. S N Talwar & Mr. R L Shenoy as Directors of the Company.
4. Appointment of M/s. BSR & Co., Chartered Accountants, Mumbai as the Auditors of the Company to hold office from the conclusion of this meeting until the conclusion of the next Annual General Meeting for the current year on remuneration, terms & conditions.
5. Appointment of Mr. Aman Bhattacharjee, Mr. K Shivkumar & Mr. E A Kshirsagar as Directors of the Company.
6. Appointment of Mr. Aman Bhattacharjee as Wholetime Director of the Company from July 16, 2007 for a period of five years on the terms & conditions.
7. Appointment of Mr. K Shivkuamr as Wholetime Director of the Company from December 13, 2007 for a period of five years on the terms & conditions
8. Approval of payment and distribution thereof a sum not exceeding one percent of the net profits of the Company, computed in accordance with the provisions of Section 198 pf the Companies Act, 1956, amongst the Directors of he Company(other than Managing Director and Wholetime Director) in such amounts or proportions and in such manner as may be decided by the Board of Directors and such payments shall be made in respect of the profits for the year ending December 31, 2008 and four succeeding years.
9. Approval of the Central Government and Reserve Bank of India, if required, the Company hereby accords its consent to the reappointment of Emerchemie NB (Ceylon) Ltd as the Sole Selling Agent of the Company for the sale and distribution of the Company’s Pharmaceutical Products, Drug Intermediates and Vitamins for a period of 5 years with effect from December 01, 2008 on a commission of 5% on F.O.B of exports and subject to the necessary terms & Conditions. |
|
|